Randomized clinical trial to compare the efficacy of ivermectin versus placebo to negativize nasopharyngeal PCR in patients with early COVID-19 in Peru (SAINT-Peru): a structured summary of a study protocol for randomized controlled trial

OBJECTIVES: The primary objective is to determine the effect of a daily dose of ivermectin administered in three consecutive days to non-severe COVID-19 patients with no more than 96 hours of symptoms, on the detection of SARS-CoV-2 RNA by PCR from nasopharyngeal swabs at day seven post-treatment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, Patricia J., Mundaca, Hansel, Ugarte-Gil, Cesar, Leon, Patricia, Malaga, German, Chaccour, Carlos, Carcamo, Cesar P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033091/
https://www.ncbi.nlm.nih.gov/pubmed/33836826
http://dx.doi.org/10.1186/s13063-021-05236-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033091/
https://www.ncbi.nlm.nih.gov/pubmed/33836826
http://dx.doi.org/10.1186/s13063-021-05236-2

Ejemplares similares